Trial population
VVC, infection, abnormal leucorrhoea symptoms, trichomonas
VAGINALIS, TRICHOMONAS, INFECTION, VULVOVAGINAL CANDIDIASIS
Women who attended the gynecology outpatient clinic of Peking University Shenzhen Hospital in China between June 2020 and April 2021 and presented with abnormal leucorrhoea symptoms were enrolled in this single-center, prospective, parallel-group, randomized controlled clinical trial. Inclusion criteria were: age of 18 - 55 years, premenopause, with a history of sexual activity, and a Nugent Score ≥ 7. Exclusion criteria were: vulvovaginal candidiasis (VVC), trichomonas vaginalis (TV) infection, This study was approved by the Peking University Shenzhen Hospital Medical Ethics Committee (ID: PUshenzhenH2020-009) and published on ClinicalTrials.gov (NCT04771728). Written consent was obtained from all subjects for this study.